Product Description
Thiothixene is a thioxanthene class typical antipsychotic drug acting principally as a 5-HT2A receptor antagonist. (Sourced from: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=212)
Mechanisms of Action: D2 Antagonist,D1 Antagonist,5-HT Antagonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Canada | India | Ireland | Italy | New Zealand | Pakistan | Taiwan | United States
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|